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Background: Neuropeptide Y (NPY) has been implicated in the modulation of pain. Under normal conditions, NPY
is found in interneurons in the dorsal horn of the spinal cord and in sympathetic postganglionic neurons but is
absent from the cell bodies of sensory neurons. Following peripheral nerve injury NPY is dramatically upregulated
in the sensory ganglia. How NPY expression is altered in the peripheral nervous system, distal to a site of nerve
lesion, remains unknown. To address this question, NPY expression was investigated using immunohistochemistry
at the level of the trigeminal ganglion, the mental nerve and in the skin of the lower lip in relation to markers of
sensory and sympathetic fibers in a rat model of trigeminal neuropathic pain.
Results: At 2 and 6 weeks after chronic constriction injury (CCI) of the mental nerve, de novo expression of NPY
was seen in the trigeminal ganglia, in axons in the mental nerve, and in fibers in the upper dermis of the skin. In
lesioned animals, NPY immunoreactivity was expressed primarily by large diameter mental nerve sensory neurons
retrogradely labelled with Fluorogold. Many axons transported this de novo NPY to the periphery as NPY-immunoreactive
(IR) fibers were seen in the mental nerve both proximal and distal to the CCI. Some of these NPY-IR axons co-expressed
Neurofilament 200 (NF200), a marker for myelinated sensory fibers, and occasionally colocalization was seen in
their terminals in the skin. Peptidergic and non-peptidergic C fibers expressing calcitonin gene-related peptide
(CGRP) or binding isolectin B4 (IB4), respectively, never expressed NPY. CCI caused a significant de novo sprouting
of sympathetic fibers into the upper dermis of the skin, and most, but not all of these fibers, expressed NPY.
Conclusions: This is the first study to provide a comprehensive description of changes in NPY expression in the
periphery after nerve injury. Novel expression of NPY in the skin comes mostly from sprouted sympathetic fibers.
This information is fundamental in order to understand where endogenous NPY is expressed, and how it might
be acting to modulate pain in the periphery.
Keywords: Neuropeptide tyrosine, NPY, Innervation, NF200, CGRP, IB4, Sympathetic nervous system, Skin, Mental
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In animal models of neuropathic pain, the landscapes of
the central (CNS) and peripheral nervous systems (PNS)
are vastly modified with some of the most striking
changes occurring in the skin, where a noxious stimulus* Correspondence: alfredo.ribeirodasilva@mcgill.ca
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unless otherwise stated.is first detected. Injury to the trigeminal or sciatic nerve
causes a loss of sensory fibers in the skin, including neu-
rofilament 200 (NF200)-immunoreactive (IR) myelinated
and calcitonin gene-relate peptide (CGRP)-IR fibers, that
transmit touch and nociceptive information, respectively
[1–5]. In these models, sympathetic fibers invade the
upper dermis of the skin, a region from where they are
normally devoid, and form close associations with sen-
sory fibers [2, 3, 6, 7]. These gross anatomical changes
are often accompanied by alterations in neurochemistry,
including changes in the peptide content of primary
afferents [8, 9].tral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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(NPY), is a tyrosine-rich peptide that is implicated in
many homeostatic roles including the modulation of
pain. In mammals, it acts by binding to its receptors, a
family of five G-protein coupled receptors (Y1, Y2, Y4,
Y5 and Y6), with the Y1 and Y2 receptors being most
heavily connected to pain mechanisms [10]. Pharmaco-
logically, NPY delivered intrathecally reduces tactile and
thermal allodynia that develop following the spared
nerve injury (SNI) model of neuropathic pain [11], and
conditional knockdown of NPY either prior to, or after
SNI, significantly increases both mechanical and cold
allodynia [12]. To complicate matters, NPY administered
subcutaneously into the paw after partial sciatic nerve
ligation (PSNL) exacerbates mechanical and thermal
allodynia [13]. While it is clear that NPY modulates pain,
its effect might be determined by its site of action.
Due to its diverse physiological roles, NPY is distributed
throughout the CNS and PNS [14]. It is colocalized with
norepinephrine in postganglionic sympathetic neurons
[15, 16] and is especially abundant in the superficial dorsal
horn (laminae I and II) [17, 18]. Following nerve injury,
large dorsal root ganglia (DRG) cell bodies, which nor-
mally do not express NPY, upregulate NPY [19–26]. In
contrast, C fibers almost never express NPY after injury
[27]. Parallel observations were seen after transection
of the mental nerve, a branch of the trigeminal nerve
that innervates the lower lip. [26].
NPY also accumulates in the neuroma that develops
proximal to sciatic nerve transection [28–30], but
whether NPY is transported through the site of injury
remains unknown. Furthermore, the innervation pattern
of NPY in the skin has never been described in a model
of chronic pain. To this end, NPY expression wasA B
Fig. 1 Bilateral chronic constriction injury of the mental nerve induced me
induced in the lower lip of the rat by applying two loose ligatures, shown in r
allodynia, von Frey fibers were applied perpendicularly to the lower lip along
where the von Frey fibers were applied. b: Sham surgery resulted in no chang
When compared to shams, CCI produced a significant reduction in 50 % with
point represents the mean ± SEM **p < 0.01, ***p < 0.001 by 1way ANOVA wiexamined in the PNS in a rat model of trigeminal
neuropathic pain in which a modified chronic constric-
tion injury (CCI) is applied to the mental nerve [3].
NPY immunoreactivity was studied in the trigeminal
ganglia, the mental nerve and in the skin of the lower
lip, in relation to markers of sensory and sympathetic
fibers, 2 and 6 weeks after CCI. We show that newly
synthesized NPY is transported in sensory neurons
through the site of injury to the skin where it can be
found in both sprouted sympathetic fibers and occa-
sionally in NF200 fibers.
Results
Bilateral chronic constriction injury of the mental nerve
induced mechanical allodynia in the lower lip
Trigeminal neuropathic pain was induced by applying a
modified version of the chronic constriction injury (CCI)
to both mental nerves which innervate the rat lower lip
(Fig. 1a). Sham surgery resulted in no change in mechanical
thresholds at any time point, so were pooled together. CCI
animals developed mechanical allodynia, seen as significant
reduction in 50 % withdrawal threshold compared to sham
animals, starting 2 weeks and persisting to 6 weeks after
surgery (Fig. 1b).
De novo expression of NPY in the trigeminal ganglia, the
skin and the mental nerve 2 and 6 weeks after CCI
CCI, in addition to causing mechanical allodynia, pro-
duced a striking de novo upregulation of NPY in the
trigeminal ganglia, the mental nerve and in the skin of
the lower lip, 2 and 6 weeks after injury, as observed
using immunohistochemistry (Fig. 2). In sham animals,
sensory cell bodies in the trigeminal ganglia almost
never expressed NPY (Fig. 2a), however after CCI, NPYchanical allodynia in the lower lip. a: Trigeminal neuropathic pain was
ed, around each mental nerve. To assess the presence of mechanical
the midline in unrestrained animals. The black arrow shows the region
e in mechanical thresholds at any time point, so were pooled together.
drawal thresholds to von Frey hairs 2–6 weeks after surgery (n = 8). Each
th Dunnett’s post hoc test





















Fig. 2 De novo expression of NPY in the trigeminal ganglia, skin and mental nerve 2 and 6 weeks after CCI. NPY-IR cell bodies are absent from
the trigeminal ganglia (TG) of sham animals (a) but are abundant 2 (b) and 6 weeks (c) after CCI. Quantification of the number of NPY-IR cell bodies
per TG section is shown in d (n = 6). NPY-IR fibers are absent from the upper dermis of sham lip skin (e), but are present in this region 2 (f) and 6 weeks
(g) after CCI. Dashed lines represent the border between the epidermis and upper dermis. Quantification of NPY fiber length (mm) per area of upper
dermis (mm2) is shown in h (n = 5–6). Parasagittal sections of mental nerve (MN) from sham (i) and CCI animals 2 (j, l) and 6 weeks (k, m) after surgery.
NPY fibers are absent from the MN of sham animals (i). In CCI animals, proximal and distal ligations are identified by rectangles labelled with p and d,
respectively and arrows identify the regions of the nerve proximal (j, k) and distal (l, m) to the ligations. Two weeks after CCI, NPY-IR fibers are present
in the nerve proximal to the ligations (j), between the ligations (j) and distal to the ligations (l). Six weeks after CCI, NPY-IR fibers are present in the nerve
proximal to the ligations (k), between the ligations (k) and distal to the ligations (m). Six week sham animals were used to show representative images
and data from 2 and 6 week sham animals were pooled for quantification. Values represent mean ± SEM *p < 0.05, ** < 0.01, ***p < 0.001 by 1 way
ANOVA with Dunnett’s post hoc test. Scale bars = 100 μm. TG: trigeminal ganglia, MN: mental nerve, p: proximal ligature, d: distal ligature
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(Fig. 2b, c). Whereas shams had an average of 0.2 ± 0.2
NPY-IR cells per section of trigeminal ganglia, CCI animals
had significantly more NPY-IR cell bodies at 2 (28.6 ± 4.8)
and 6 weeks (21 ± 2.5) after surgery (Fig. 2d). NPY immu-
noreactivity was observed in cells with a mean diameter of
36.4 ± 0.6 μm (2 week CCI) and 34.7 ± 1.4 μm (6 weekCCI), indicating that it predominantly became expressed in
large trigeminal ganglion neurons.
In the skin of the lower lip, NPY immunoreactivity
was also increased (Fig. 2e–g). We focused our investiga-
tion on the upper dermis of the skin as innervation
changes in this area have been widely reported in many
models of chronic pain [1–3, 6, 7, 31, 32]. In shams,
Magnussen et al. Molecular Pain  (2015) 11:31 Page 4 of 12almost no NPY immunoreactivity was observed (Fig. 2e),
however after CCI, NPY-IR fibers were readily seen in
the upper dermis (Fig. 2f, g). NPY fiber density, as mea-
sured by fiber length (mm) per area of upper dermis
(mm2), was significantly greater than in sham at both
time points after CCI (Fig. 2h; Sham 0.032 ± 0.02; 2 week
CCI 0.4 ± 0.07, p < 0.01; 6 week CCI 0.3 ± 0.07, p < 0.05).
NPY immunoreactivity was not seen in the mental
nerve of sham animals (Fig. 2i), but 2 and 6 weeks after
CCI, many NPY-IR fibers were found proximal to the
first ligature. These fibers passed through both the first
and second ligatures (Fig. 2j, k), and could be seen run-
ning in the nerve distal to injury (Fig. 2l, m).
NPY was expressed in Fluorogold labelled mental nerve
cell bodies after CCI
The increase in NPY immunoreactivity in the trigeminal
ganglia after CCI was evident, but was this upregulation
occurring specifically in the cell bodies of mental nerve
sensory neurons, or was it occurring through the entire
trigeminal ganglia? To address this question, Fluorogold




Fig. 3 NPY was expressed in Fluorogold labelled mental nerve cell bodies
cell bodies of mental nerve sensory neurons. NPY immunoreactivity is show
in the adjacent larger panel. Colocalization of the two signals is shown in t
animals many NPY cells colocalized with FG (b). Arrows indicate examples
expressed NPY is shown in c. The quantification of the percentage of NPY
(n = 6); *p < 0.05, ***p < 0.001 by Student’s t-test. Scale bar = 100 μmCCI surgery to retrogradely label the cell bodies of the
mental nerve sensory neurons. NPY expression in these
cells was evaluated 1 week after injection. Unlike a normal
sham surgery which does not provoke the upregulation of
NPY, injection of Fluorogold was sufficient to produce a
small increase in NPY immunoreactivity in the ganglia of
sham animals (Fig. 3a). However, after CCI, a significantly
higher percentage of Fluorogold cells expressed NPY
(Fig. 3b, c; Sham 19.2 ± 2.7 %; CCI 58.5 ± 1.3 %, p < 0.001).
In both sham and CCI, NPY was not expressed exclusively
by Fluorogold-labelled cells (Fig. 3d; Sham 45.0 ± 5.7 %;
CCI 67.4 ± 5.7 %, p < 0.05).
NPY was expressed by some NF200-IR sensory neurons
after CCI
To determine in which population of sensory fibers NPY
became expressed in after nerve injury, NPY immunore-
activity was studied in relation to NF200 (Fig. 4), a
marker of myelinated fibers, CGRP (Fig. 5), a marker for
small diameter peptide containing nociceptive fibers and
IB4 (Fig. 6), a marker for small diameter non-peptidergic
nociceptive fibers. Following CCI, there was a de novoD
CCIB
after CCI. Fluorogold (FG), in blue, was used to retrogradely label the
n in green. Signals are shown separately in small panels, and together
urquoise. Few NPY cells were seen in sham animals (a), but in CCI
of colocalization. The quantification of the percentage of FG cells that
cells that expressed FG is shown in d. Values represent mean ± SEM
















Fig. 4 NPY was expressed by some NF200-IR sensory neurons after CCI. The presence of NPY immunoreactivity (in green) in NF200-positive sensory
fibers (in red) was assessed in sham animals and in CCI animals 2 and 6 weeks after injury in the trigeminal ganglia (TG), the mental nerve (MN) and in
the upper dermis of the skin. Colocalization between these two markers is shown in yellow and highlighted with an arrow. NPY was not seen in the
TG of sham animals (a), but was expressed in some NF200-IR cell bodies 2 (b) and 6 weeks (c) after CCI. The percentage of NF200-IR cells that expressed
NPY was quantified (Sham 0 ± 0; 2 week CCI 28.7 ± 5.4 %; 6 week CCI 21.1 ± 2.5 %; n = 6). The percentage of NPY-IR cells that expressed NF200 was
quantified (Sham 0 ± 0; 2 week CCI 57.5 ± 3.8 %; 6 week CCI 48.5 ± 5.1 %; n = 6). No NPY-IR fibers were seen in the MN of sham animals (d). Two (e)
and 6 weeks (f) after CCI some NF200 fibers distal to the ligation expressed NPY. NPY was also seen proximal to the ligation (inset in e-f). In the skin,
NF200 fibers were present in the upper dermis of sham animals (g). NF200 fiber density was reduced in the skin after CCI and some NF200
fibers expressed NPY immunoreactivity 2 (h) and 6 weeks (i) after CCI. Dashed lines represent the border between the epidermis and the
upper dermis. In all cases, 6 week sham animals were used as representative images and data from 2 and 6 week sham animals were pooled
for quantification. Scale bar = 50 μm TG: trigeminal ganglia, MN: mental nerve
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rons (Fig. 4a–c). In sham animals, no NPY-IR cell bodies
were seen (Fig. 4a), however 2 and 6 weeks after CCI,
28.7 ± 5.4 % and 21.1 ± 2.5 % of NF200-IR cells
expressed NPY, respectively (n = 6). Not all NPY-IR cellbodies expressed NF200 after CCI, with about 50 % of
NPY-IR cells also NF200-IR (2 week CCI 57.5 ± 3.8 %;
6 week CCI 48.5 ± 5.1 %). This NPY seemed to be trans-
ported peripherally in the axons of these neurons, as












Fig. 5 NPY was not expressed by CGRP-IR sensory neurons after CCI. The presence of NPY (in green) in CGRP-positive primary afferents (in red)
was assessed after CCI in the trigeminal ganglia (TG), the mental nerve (MN) and in the upper dermis of the skin. Representative images were
taken from a CCI animal 6 weeks after surgery, but the same pattern was observed at 2 weeks (data not shown). NPY immunoreactivity was
expressed by some cell bodies in the TG as well as by fibers, but these never co-expressed CGRP (a). NPY-IR fibers were seen in the mental nerve
both proximal (inset) and distal to the CCI, but these fibers never co-expressed CGRP (b). In the skin, NPY-IR fibers never colocalized with CGRP,
but were sometimes seen in close proximity (c). Dashed lines represent the border between the epidermis and the upper dermis. Scale bar = 50 μm
TG: trigeminal ganglia, MN: mental nerve
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(Fig. 4e, f ). In the skin, NF200 fiber density in the upper
dermis was significantly reduced after CCI compared to
sham (Fig. 4g), however occasionally NF200 fibers
expressed NPY in the skin of CCI animals (Fig. 4h-i).
After extensive qualitative examination, the amount of
colocalization between NF200 and NPY appeared to beNPY/IB4
Fig. 6 NPY was not expressed by IB4 binding sensory neurons after
CCI. The presence of NPY (in green) in IB4 binding primary afferents
(in red) was assessed in the trigeminal ganglia (TG) after CCI. This
representative image was taken from a CCI animal 6 weeks after
surgery, but the same pattern was observed at 2 weeks (data not
shown). NPY immunoreactivity was expressed by some cell bodies
in the TG, but these did not bind IB4. Scale bar = 50 μmgreatest in the trigeminal ganglia, with less colocalization
observed in the mental nerve and even lesser colocaliza-
tion in the skin.
NPY was not expressed by small CGRP-IR or IB4-binding
sensory neurons after CCI
In contrast to NF200, CGRP-IR neurons never expressed
NPY after CCI (Fig. 5). Images from a 6 week CCI were
chosen for illustration, and it is evident that CGRP and
NPY were never found together in the trigeminal ganglia
(Fig. 5a) nor in the mental nerve proximal (inset) or dis-
tal to the ligation (Fig. 5b). The same was true 2 weeks
after CCI (data not shown). In the skin, NPY and CGRP
fibers never colocalized, however they could be seen to
run alongside one another (Fig. 5c). Because NPY is almost
never upregulated in C fibers after injury [27], IB4-binding
non-peptidergic neurons were not expected to express
NPY. As predicted, IB4+ cell bodies in the trigeminal
ganglia did not express NPY after CCI (Fig. 6).
CCI induced a sprouting of sympathetic fibers into the
upper dermis of the skin, and these fibers often
expressed NPY
Sympathetic fibers normally express DBH, as well as
NPY. In the trigeminal ganglia of both sham and CCI
animals, sympathetic fibers were occasionally seen either
around blood vessels or along the capsule of the ganglia,
and these fibers colocalized DBH and NPY (data not
shown). In the skin, sympathetic fibers were almost
never seen in the upper dermis of sham animals (Fig.7a),
but 2 and 6 weeks after CCI, they sprouted into this ter-
ritory and many expressed NPY (Fig. 7b, c). While there
was a large trend towards an increase in sympathetic
FED













Fig. 7 CCI induced a sprouting of sympathetic fibers into the upper dermis of the skin, and these fibers often expressed NPY. Sympathetic fibers
labelled with DBH (in red), were rarely observed in the upper dermis of the skin in 6 week sham animals (a). 2 (b) and 6 (c) weeks after CCI,
sympathetic fibers sprouted into the upper dermis, and many expressed NPY. The quantification of the number of DBH fibers per mm of upper
dermis is shown in (d). The quantification of the percentage of DBH fibers that expressed NPY is shown in e and the values written on the
graphs indicate the absolute number of sprouted sympathetic fibers counted across animals. The quantification of the percentage of NPY fibers
that expressed DBH is shown in f and the values written on the graphs indicate the absolute number of NPY-positive fibers counted across
animals. Dashed lines represent the border between the epidermis and the upper dermis. **p < 0.01 by 2 way ANOVA with Bonferroni post
hoc (n = 6). Scale bar = 50 μm
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when the number of DBH-IR fibers increased from 0.18 ±
0.05/mm in sham to 3.0 ± 0.72/mm in CCI, p < 0.01
(Fig. 7d). Many, but not all, sprouted DBH-IR fibers
expressed NPY, and the percentage of colocalization
between these two markers increased over time in CCI
animals (Fig. 7e; 2 week Sham 0 ± 0 %, 2 week CCI
76.1 ± 10.6 %; 6 week Sham 75 ± 14.4 %, 6 week CCI
90.8 ± 4.8 %). While it was possible to calculate a per-
centage of colocalization between these two markers in
all 4 groups of animals, the absolute number of
sprouted sympathetic fibers varied considerably between
groups with 2, 151, 10 and 256 fibers in the upper dermis
of 2 week sham, 2 week CCI, 6 week sham and 6 week
CCI animals, respectively. After CCI, not all NPY-IR struc-
tures were sympathetic fibers, and this is reflected by the
percentage of NPY fibers that expressed DBH (Fig. 7f;
2 week Sham 0 ± 0 %, 2 week CCI 49.4 ± 11.0 %; 6 week
Sham 87.5 ± 12.5 %, 6 week CCI 82.4 ± 3.2 %). The abso-
lute number of NPY fibers in the upper dermis per group
was 0, 274, 7 and 286 in 2 week sham, 2 week CCI, 6 week
sham and 6 week CCI, respectively.Discussion
This study is the first to demonstrate significant in-
creases in NPY immunoreactivity distal to a site of per-
ipheral nerve injury. Our results suggest that newly
synthesized NPY in the trigeminal ganglia is transported
in the axons of many sensory fibers, including a few
remaining NF200 primary afferents, through the lesion
in the mental nerve, to their terminations in the skin.
However, most of the de novo NPY in the upper dermis
of the skin originated from sprouted sympathetic fibers,
which do not travel in the mental nerve [6].
The de novo expression of NPY in large diameter cell
bodies is consistent across many different models of
neuropathic [19, 22, 23, 25, 33] and trigeminal neuro-
pathic pain [26, 34–36]. Here we report that NPY be-
came expressed in trigeminal ganglia neurons with an
average diameter of 36.4 μm at 2 weeks after CCI of the
mental nerve, consistent with what has been reported
after mental nerve transection [26]. Based on the size of
these NPY-IR cell bodies, it is not surprising that
roughly 50 % also expressed NF200, a reliable marker of
Aβ and Aδ fibers [27]. Based on existing literature, C
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pected to express NPY after CCI [27], and as anticipated,
NPY never colocalized with CGRP or IB4 in the ganglia.
The exact triggers that result in the do novo expression
of NPY by sensory neurons remain unknown. However,
it has been proposed that nerve trauma, and not pain
per se, might be the precipitating factor since painful in-
flammation does not increase DRG NPY immunoreactiv-
ity [23, 37]. In models of neuropathic pain, the expression
of NPY seems to correlate with the extent of nerve injury
[36, 38, 39] and in our hands, a small trauma, like the one
that occurred when Fluorogold was injected into the
nerve, triggered a limited NPY expression in the ganglia of
sham animals. 1 week after CCI, the majority (67 %) of
NPY-IR cells also expressed Fluorogold, indicating a certain
spatial specificity to this response. Because Fluorogold is
not taken up by intact axons at nonterminal sites [40], this
technique was used to retrogradely label injured neurons,
and underestimates the total number of mental nerve sen-
sory neurons. While we and the literature agree that NPY
is expressed by injured sensory neurons [21, 25, 41], our re-
sults suggest that a smaller proportion of uninjured neu-
rons also begin to express NPY after CCI, in agreement
with Ma and Bisby [41]. This is not the case after median
nerve transection where only 1 % of uninjured neurons
expressed NPY [25].
We suggest that these uninjured neurons are the first
to transport NPY through the site of injury in the mental
nerve. While many NPY-IR fibers are seen in the nerve,
only some co-express NF200. In fact, the colocalization
between NF200 and NPY appears to be the greatest in
the ganglia, with lower levels observed in the nerve and
in the skin, respectively. This is unlikely due to slow
shipment of the peptide to the periphery as NPY, synthe-
sized in the cell body, is sent by fast axonal transport at
a rate of approximately 9 mm/h [42]. Given that its
mRNA and protein are increased as early as 3 days after
nerve injury [25, 35, 43], NPY could theoretically reach
the terminals of NF200 fibers only 4 days after CCI. In-
stead the reduced colocalization between these two
markers in distal nerves is most likely explained by the
findings that 90 % of A fibers did not conduct impulses
through the site of injury 3 days after CCI [44] and that
NF200 fiber density in the skin is drastically reduced up
to 16 weeks after CCI [1]. As NPY immunoreactivity re-
mains increased in the ganglia up to 24 weeks after
nerve injury [21], it is possible that greater colocalization
between NF200 and NPY could be observed distal to
CCI at these later time points when there is more
NF200 fiber recovery. The induction of NPY in these
sensory fibers may reflect a mechanism for altered neur-
onal activity after injury. Indeed, following spinal nerve
ligation, Aβ DRGs from NPY overexpressing mice dis-
played longer refractory periods and had higher voltagethresholds compared to wild type animals, indicating
that NPY in surplus can decrease the responses of these
fibers to nerve injury [45].
While NF200 fibers represent a minor source of de
novo NPY in the skin, sprouted sympathetic fibers,
which invade the upper dermis at 2 weeks [3, 7] repre-
sent the major source. The colocalization between DBH
and NPY increased over time, and by 6 weeks after CCI
approximately 90 % of DBH-IR sprouted sympathetic
fibers expressed NPY. NPY is co-expressed with nor-
epinephrine in many sympathetic fibers [42, 46, 47],
however there exists heterogeneity within this popula-
tion and not all fibers contain NPY [16]. In our model,
previous studies have shown evidence that these ectopic
fibers migrate from the lower dermis [3, 6], where sym-
pathetic fibers predominantly innervate vasculature and
almost always contain NPY (unpublished observations).
We are therefore not surprised that these sprouted sym-
pathetic fibers mostly maintain their original phenotype.
Normally, NPY is preferentially released following high
frequency stimulation and leads to long lasting vasocon-
striction [48], however because these sprouted sympa-
thetic fibers are most often not associated with blood
vessels, they may function in a different capacity after
nerve injury. Finally, because our data indicate that total
NPY immunoreactivity in the upper dermis cannot be
explained alone by its expression in sympathetic fibers,
NPY should not be used as a reliable marker of this fiber
population after nerve injury.
In this study, we show two novel sources of NPY in
the upper dermis of the skin after CCI, however how
this increased NPY contributes to pain is difficult to dir-
ectly examine. Mental nerve CCI resulted in mechanical
allodynia that lasted from 2 to 6 weeks, the last time
point tested. Because neither the withdrawal thresholds
nor levels of NPY changed significantly during this time,
we are unable to correlate alterations in NPY immunoreac-
tivity in the periphery with pain behaviour. In the literature
however there is considerable evidence in support of the
idea that upregulation of NPY by sensory neurons repre-
sents an adaptive mechanism that counteracts the evolution
of neuropathic pain [27]—for reviews see [10, 49]. Indeed,
conditional knockdown of NPY resulted in a significant
increase in the intensity and duration of mechanical
and thermal hypersensitivity after SNI suggesting that
NPY inhibits pain [12].
In the periphery, the situation might be different, with
NPY being pronociceptive through its action at Y2 recep-
tors, or having mixed effects through the Y1 receptor.
Subcutaneous injections of NPY and an NPY Y2 receptor
agonist into the paw after PSNL exacerbated mechanical
allodynia and thermal hyperalgesia [13]. Could NPY re-
leased from these sprouted sympathetic fibers worsen
pain? A novel physical proximity exists between sprouted
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[2, 3, 6, 7], and we have shown here that NPY fibers
run in bundles with CGRP fibers in the skin. It is con-
ceivable that NPY released from these fibers could dir-
ectly modulate the activity of primary afferents, known
to express Y1 and Y2 [50–53]. Indeed, NPY through its
actions on Y2 increased the excitability of sensory neu-
rons [54]. Alternatively, NPY might act directly on
these sprouted sympathetic fibers, through Y2 autore-
ceptors [55], to modulate the release of excitatory nor-
epinephrine, or even NPY itself [13, 56, 57]. NPY in the
skin can also act on Y1 receptors, and it has been
shown that an intraplantar injection of a Y1 agonist
worsens mechanical hyperalgesia, while concurrently
improving thermal hyperalgesia after PSNL [13]. In
models involving neurogenic inflammation, Y1 agonists
inhibit capsaicin evoked mechanical allodynia through a
reduction in CGRP release from primary afferent termi-
nals [58]. Thus the effects of NPY in the skin are ex-
tremely complex, and depend on the receptor on which it
acts, the location of these receptors, and the model used.
Not all of the NPY immunoreactivity has been accounted
for as many NPY-IR cell bodies and axons were not shown
to co-express any of the markers used in this study. Future
studies will be required to identify these primary afferents,
however it is expected that they will likely possess medium
to large diameter cell bodies and send central projections to
lamina III and IV.
In conclusion, these results show novel and increased
sources of NPY in the periphery in a rat model of tri-
geminal neuropathic pain. How exactly this increase in




Adult male Sprague-Dawley rats (250–350 g; Charles
River, Canada) were maintained on a 12-h light/dark
cycle and allowed access to food and water ad libitum.
All protocols were approved by the McGill University
Animal Care Committee and complied with the policies
and guidelines outlined by the Canadian Council on
Animal Care and the International Association for the
Study of Pain.
Surgical procedures
A modified chronic constriction injury [59], as described
previously [3], was applied to the mental nerve of the
rat, a purely sensory branch of the trigeminal nerve that
innervates the rat lower lip [6]. Briefly, the animals were
anesthetized with isofluorane and the mental nerves
were bilaterally exposed from their point of exit from
the mental foramina. Proximal to its branching, the
nerve was freed from adhering tissue and 2 loose silkligatures (8.0, Covidien), separated by approximately
2 mm, were tied around the nerve. The incision was
closed with absorbable sutures (Vicryl, Ethicon). A sham
surgery, where the mental nerve was visualized but no
sutures were applied, was used as a control.
Fluorogold injections
Because the trigeminal ganglion contains the sensory
neurons from all three branches of the trigeminal nerve,
Fluorogold was used to determine if the upregulation of
NPY was occurring specifically in the cell bodies of men-
tal nerve sensory neurons, or if it was occurring globally
throughout the ganglion. Using a calibrated glass micro-
pipette, 1 μl of 5 % Fluorogold solution (Fluorochrome,
LLC) diluted in distilled water was injected directly into
the mental nerve of sham and CCI animals, proximal to
the first suture. As above, the incision was closed with
absorbable sutures. Animals were sacrificed one week
after injection.
Behaviour: mechanical allodynia
All animals (n = 8/group) were tested 2–6 weeks following
CCI surgery by a blinded experimenter. We used von Frey
filaments applied to the lower lip to determine the 50 %
withdrawal threshold to punctate mechanical stimulation.
Each rat was placed in a transparent Plexiglas cage atop a
wire mesh grid and was allowed to habituate to their
surroundings for 30 min before behaviour testing. Von
Frey filaments of increasing stiffness were applied perpen-
dicularly, in the midline, to the lower lip skin following the
up-and-down method described by Dixon [60] until a
positive reaction, considered a brisk head withdrawal, was
observed [7]. Following the first positive reaction, the next
lighter filament was applied. If no reaction, the next stiffer
filament was applied; if a reaction was observed, the next
lighter filament was applied. After the first positive fila-
ment, four additional filaments were applied and the 50 %
withdrawal threshold was calculated using the methods
outlined by Chaplan et al. [61]. Mechanical allodynia was
considered as a significant reduction in withdrawal
threshold when compared to shams, as measured by a
1way analysis of variance (ANOVA) with Dunnett’s post
hoc test. Statistical significance was set at p < 0.05.
Tissue preparation
NPY expression in the trigeminal ganglion, the mental
nerve and in the skin of the lower lip following CCI
was visualized using immunohistochemistry. Rats were
deeply anesthetized with Equithesin (0.3 mL/100 g) and
perfused transcardially with 100 mL of perfusion buffer
and 500 mL of 3 % paraformaldehyde and 15 % satu-
rated picric acid (v/v) in 0.1 M phosphate buffer (PB),
pH 7.4, for 30 min. Trigeminal ganglia, mental nerves
and hairy lower lip skin were dissected out and postfixed
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crose in PB for 24 h at 4 °C. Tissue was embedded in an
optimum cutting temperature medium (Tissue Tek, OCT)
and cut on a cryostat at − 20 °C. Parasagittal sections of
mental nerve and horizontal sections of trigeminal ganglia
were cut at a thickness of 14 μm and 20 μm, respectively,
and mounted directly on slides. Sections of skin were cut
at 50 μm and collected as free-floating in 0.01 M
phosphate-buffered saline (PBS).
Immunohistochemisty and lectin binding
To determine in which population of fibers NPY was
expressed in after CCI, the mental nerves, trigeminal
ganglia and skin were processed for immunohistochemistry
using antibodies against NPY in combination with those
against either neurofilament 200 (NF200), calcitonin gene-
related peptide (CGRP) or dopamine β-hydroxylase (DBH)
to label myelinated fibers, peptidergic sensory fibers and
sympathetic fibers, respectively. The lectin IB4 was used to
identify non-peptidergic sensory fibers. Fluorogold is a
fluorescent dye and requires no additional staining. All sec-
tions were washed for 30 min with PBS containing 0.2 %
Triton-X (PBS-T), incubated in 50 % ethanol for 30 min
and washed in PBS-T. Depending on the species in which
the secondary antibody was raised in, the tissue was either
blocked in 10 % normal donkey or normal goat serum for
1 h. Primary antibodies were used at the following concen-
trations – anti-NPY (1:4000, Rabbit polyclonal, Abcam,
ab10980, lot#GR16697-2), anti-NF200 (in skin and nerve,
1:5, mouse monoclonal, Abcam, ab910, lot# GR130394-2;
in ganglia, 1:1000, mouse monoclonal, Sigma, N0142, lot#
053 M4756), anti-CGRP (1:1000, mouse monoclonal,
Sigma, C7113, lot#032 M4862), anti-DBH (1:50, mouse
monoclonal, Medimabs, MM-0008-P, lot#83120927-P) and
IB4 conjugated to Alexa Fluor 568 (1:200, Molecular
Probes, I21412, lot#880292) made in 5 % blocking serum
(goat or donkey) in PBS-T and left to incubate overnight on
the shaker at 4 °C. Following 30 min of washes with PBS-T,
the tissue was incubated with the appropriate secondary
antibody diluted in PBS-T for 2 h at room temperature–
goat anti-rabbit conjugated to Alexa Fluor 488 (1:800,
Molecular Probes, A11034, lot#1212189), goat anti-
mouse conjugated to Alexa Fluor 568 (1:800, Molecular
Probes, A11031, lot# 822389), or donkey anti-mouse
conjugated to Rhodamine Red X (1:200, Jackson Immu-
noresearch, 715-296-151, lot#72430). Following 30 min
of washes, free-floating lip sections were mounted on
gelatin-subbed slides and all slides were coverslipped
with Aqua Polymount (Polysciences).
Representative images were taken using a Zeiss LSM510
confocal microscope equipped with Ar and He-Ne lasers
using either 10× dry, 40× water-immersion, or 63× oil-
immersion objectives. For co-localization studies both z
stack and single optical slice images were taken to ensurebona fide detection of co-localization between markers.
In the figures, all images of the mental nerve and trigemi-
nal ganglia are single plane images, with z stack images of
the skin.
Quantification
Images used for quantification were taken on a Zeiss
Axioplan 2e imaging fluorescence microscope (Carl Zeiss
Microscopy LLC), with either a 20× or a 40× objective.
Images were acquired with a high-resolution color digital
camera with Zeiss Axiovision 4.8 software.
NPY fiber density quantification in the skin
Changes in NPY-IR innervation in the lower lip skin
were determined by analyzing the density of fibers
within the upper dermis, defined as the area above the
opening of the sebaceous glands [6]. Six randomly
chosen fields per lip section from 3 sections were cap-
tured, totaling 18 images per animal. Six animals were
used for each time point. Quantification was performed
using an MCID Elite image analysis system (Imaging Re-
search Inc., St. Catharines, ON, Canada) to determine
the total fiber length (mm) per unit area of upper dermis
(mm2), as described by us previously [7]. Briefly, we used
a function of the MCID software that was developed to
specifically and accurately detect fibers. After detection,
fibers were skeletonized to 1 pixel in width, and the total
fiber length per unit area was determined by the soft-
ware and compared using an ANOVA with Dunnett’s
post hoc test, with p < 0.05 considered significant.
Trigeminal ganglia quantification
To determine the changes in NPY expression in the tri-
geminal ganglia, 3 entire sections per ganglion (and per
animal) were captured using the 20× objective. From
these images, the numbers of NPY-IR cell bodies with
visible nuclei were counted. In addition the diameter of
NPY-IR cells was measured using the Axiovision software.
The extent of colocalization between NPY and either
Fluorogold, CGRP, IB4 or NF200, was determined by
counting both the total number of cell bodies expressing
each individual marker as well as those labelled with both
markers. A percentage was calculated from these values
and when applicable was compared using a Student t-test
with p < 0.05 considered significant.
Quantification of NPY/DBH colocalization in the skin
Three random sections per animal were visualized using
the 40× objective from the fluorescence microscope and
all of the DBH-IR and NPY-IR fibers in the upper dermis
were counted, taking note of whether the fiber was also
NPY-IR or DBH-IR, respectively. Total section length
was measured in ImageJ. The number of DBH-IR fibers
per section length (mm) as well as the percentage of
Magnussen et al. Molecular Pain  (2015) 11:31 Page 11 of 12DBH fibers expressing NPY or NPY fibers expressing
DBH was calculated and in all cases was compared using
a 2 way ANOVA with Bonferroni post-hoc analysis with
p < 0.05 considered significant.
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